- Home
- SOTK vs BRNS Comparison
SOTK vs BRNS Comparison
Compare SOTK & BRNS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SOTK
- BRNS
- Stock Information
- Founded
- SOTK 1975
- BRNS 2016
- Country
- SOTK United States
- BRNS United Kingdom
- Employees
- SOTK N/A
- BRNS N/A
- Industry
- SOTK Industrial Machinery/Components
- BRNS Biotechnology: Pharmaceutical Preparations
- Sector
- SOTK Technology
- BRNS Health Care
- Exchange
- SOTK Nasdaq
- BRNS Nasdaq
- Market Cap
- SOTK 52.1M
- BRNS 48.3M
- IPO Year
- SOTK 1987
- BRNS 2021
- Fundamental
- Price
- SOTK $3.91
- BRNS $1.10
- Analyst Decision
- SOTK Hold
- BRNS Strong Buy
- Analyst Count
- SOTK 1
- BRNS 1
- Target Price
- SOTK N/A
- BRNS $3.00
- AVG Volume (30 Days)
- SOTK 28.0K
- BRNS 37.9K
- Earning Date
- SOTK 10-14-2025
- BRNS 11-05-2025
- Dividend Yield
- SOTK N/A
- BRNS N/A
- EPS Growth
- SOTK N/A
- BRNS N/A
- EPS
- SOTK 0.09
- BRNS N/A
- Revenue
- SOTK $20,606,116.00
- BRNS $14,969,000.00
- Revenue This Year
- SOTK $0.56
- BRNS N/A
- Revenue Next Year
- SOTK $8.95
- BRNS N/A
- P/E Ratio
- SOTK $43.45
- BRNS N/A
- Revenue Growth
- SOTK N/A
- BRNS 1766.46
- 52 Week Low
- SOTK $3.23
- BRNS $0.64
- 52 Week High
- SOTK $6.05
- BRNS $2.92
- Technical
- Relative Strength Index (RSI)
- SOTK 64.13
- BRNS 42.78
- Support Level
- SOTK $3.82
- BRNS $1.08
- Resistance Level
- SOTK $4.23
- BRNS $1.20
- Average True Range (ATR)
- SOTK 0.18
- BRNS 0.09
- MACD
- SOTK 0.07
- BRNS -0.01
- Stochastic Oscillator
- SOTK 65.59
- BRNS 7.41
About SOTK Sono-Tek Corporation
Sono-Tek Corp design and manufacture of ultrasonic coating systems for applying precise, thin film coatings to add functional properties, protect or strengthen surfaces on parts and components for the microelectronics/electronics, alternative energy, medical, industrial and emerging research & development/other markets. The company design and manufacture custom-engineered ultrasonic coating systems incorporating its patented technology, in combination with strong applications engineering knowledge, to assist its customers in achieving their desired coating solutions.
About BRNS Barinthus Biotherapeutics plc
Barinthus Biotherapeutics PLC is a clinical-stage biopharmaceutical company developing novel T-cell immunotherapeutics that guide the immune system to overcome chronic infectious diseases, autoimmunity, and cancer. The company operates as one segment, the research and development of immunotherapies and vaccines.